{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1112","meta":{"versionId":"22","lastUpdated":"2021-02-02T11:26:10.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-02-02"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1112","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1112"}],"version":"20170826","name":"Pentazocine","title":"Pentazocine","status":"active","experimental":false,"date":"2017-08-26T01:00:05-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for pentazocine medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, prescribable pentazocine and pentazocine in combination with other medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs and concepts that represent components or ingredients.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"238133","display":"Pentazocine 30 MG/ML Injectable Solution"}]}]},"expansion":{"identifier":"urn:uuid:7f76860f-f817-4e32-b38c-436cbf6a8fbe","timestamp":"2023-12-11T02:29:57-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"238133","display":"pentazocine 30 MG/ML Injectable Solution"}]}}